Home / RIPK3 Knockout Cell Lines

RIPK3 Knockout Cell Lines

Gene: RIPK3

Official Full Name: receptor interacting serine/threonine kinase 3provided by HGNC

Gene Summary: The product of this gene is a member of the receptor-interacting protein (RIP) family of serine/threonine protein kinases, and contains a C-terminal domain unique from other RIP family members. The encoded protein is predominantly localized to the cytoplasm, and can undergo nucleocytoplasmic shuttling dependent on novel nuclear localization and export signals. It is a component of the tumor necrosis factor (TNF) receptor-I signaling complex, and can induce apoptosis and weakly activate the NF-kappaB transcription factor. [provided by RefSeq, Jul 2008]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO00545 RIPK3 Knockout cell line (HEK293) Human RIPK3 1:3~1:6 Negative Online Inquiry
KO01271 RIPK3 Knockout cell line (PK-15) Pig RIPK3 1:2-1:4 Negative Online Inquiry

Background

RIPK3 Gene Knockout Cell Lines are specialized cellular models that have undergone targeted genetic modification to disrupt the expression of the receptor-interacting protein kinase 3 (RIPK3). This gene plays a crucial role in various cellular processes, particularly in the regulation of programmed necrosis and inflammation, making these knockout lines vital for understanding the complex mechanisms of cell death and immune response.

The primary function of RIPK3 involves orchestrating necroptosis, a form of regulated necrotic cell death that is activated under specific stress conditions or during viral infections. By knocking out the RIPK3 gene, researchers can investigate the effects of this signaling pathway, providing insights into the cross-talk between cell death and inflammation, as well as implications in diseases such as cancer, neurodegeneration, and autoimmune disorders.

In research and clinical applications, RIPK3 Gene Knockout Cell Lines serve as powerful tools for elucidating the pathophysiology of various illnesses and screening potential therapeutic targets. Their utility extends to drug development, where scientists can assess how inhibiting RIPK3 affects disease progression or treatment efficacy. Furthermore, these cell lines can be integrated into high-throughput screening platforms, facilitating the discovery of new pharmacological agents.

What sets our RIPK3 Gene Knockout Cell Lines apart from alternative models is not only the specificity of the gene disruption but also the meticulous validation through sequencing and functional assays, ensuring consistent performance across experiments. This level of precision reduces experimental variability and enhances reproducibility in research findings.

For researchers and clinicians aiming to further their understanding of cellular death mechanisms or to develop innovative therapies, our RIPK3 Gene Knockout Cell Lines provide invaluable insights and tools. They empower users to build on established knowledge while paving the way for novel discoveries in the field of cell biology and therapeutics. With our extensive expertise in genetic engineering and commitment to advancing scientific understanding, we support researchers with high-quality products that drive innovation and discovery.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.